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Abstract Retinal dehydrogenase (RALDH) catalyzes the
oxidation of retinal to all-trans and 9-cis retinoic acid, which
function as ligands controlling RAR and RXR nuclear receptor-
signaling pathways. We have recently shown the expression of
RALDH transcript in the stomach and small intestine by reverse
transcription polymerase chain reaction [Bhat, P.V., Labrecque
J., Dumas, F., Lacroix, A. and Yoshida, A. (1995) Gene 166,
303^306]. We have examined RALDH expression in the stomach
and small intestine before and during postnatal development and
in vitamin A deficiency by assaying for mRNA levels and protein
as well as for enzyme activity. In 32 day fetuses, RALDH
expression was high in the small intestine, whereas RALDH
protein was not detectable in the stomach. However, expression
of RALDH was seen in the stomach after birth, and gradually
increased with age and reached the highest level at postnatal day
42. In the intestine, RALDH expression decreased postnatally.
Vitamin A deficiency up-regulated RALDH expression in the
stomach and small intestine, and administration of retinoids
down-regulated the RALDH expression in these tissues. These
results show the differential expression of RALDH in the
stomach and small intestine during postnatal development, and
that vitamin A status regulates the expression of RALDH gene
in these tissues.
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1. Introduction
Retinoic acid (RA), an active metabolite of vitamin A, is
essential for growth, development, and maintenance of nor-
mal cellular di¡erentiation [1^3]. RA regulates gene transcrip-
tion acting through ligand-dependent transcription factors:
the RA receptors (RARs) and the retinoid X receptors
(RXRs) [4,5]. The pathway of RA synthesis involves ¢rst
the oxidation of retinol to retinal and then the oxidation of
retinal to RA [6,7]. We previously reported an aldehyde de-
hydrogenase designated retinal dehydrogenase (RALDH)
from rat kidney that was able to oxidize retinal to all-trans
and 9-cis RA [8,9]. Recently, we identi¢ed RALDH tran-
scripts in the stomach and small intestine of rats by reverse
transcription polymerase chain reaction [10]. We have also
shown that the expression of RALDH mRNA is primarily
in the epithelial lining of these tissues by in situ hybridization
[11].
Vitamin A is essential for the maintenance of the epithelial
structure of the stomach and small intestine [12]. In vitamin A
de¢ciency, the forestomach shows hyperkeratosis and the
number of goblet cells of the small intestine severely declines
[13]. Because RA is involved in the epithelial cell di¡erentia-
tion of the stomach and small intestine, and also because the
endogenous RA levels in embryonic tissues are controlled by
developmentally regulated mechanisms that are likely to in-
clude modulation of expression and/or activity of enzymes
catalyzing RA synthesis [14,15], it was of interest to examine
the developmental pattern of RALDH gene expression in
these epithelial tissues. Further, we also studied the e¡ects
of vitamin A status on RALDH gene expression in these
tissues.
2. Materials and methods
2.1. Materials
Vitamin A de¢cient diet containing AIN-76 salt mixture [16] was
obtained from ICN Nutritional Biochemicals, Cleveland, OH. Reti-
noids leupeptin, pepstatin and phenylmethylsulfonyl £uoride (PMSF)
were purchased from Sigma, St. Louis, MO. TRI pure isolation re-
agent was obtained from Boehringer Mannheim. Quickhyb reagent,
random priming kit for Northern analysis were purchased from Stra-
tagene. Enhanced chemiluminescence (ECL) reagents were from
Pierce.
2.2. Animals
Sprague-Dawley rats were obtained from Canadian Breeding Farm,
Quebec. Fetuses were delivered by cesarian section on day 19 of
pregnancy (32 days). For Northern blot, Western blot and enzyme
assay analysis, the organs from fetuses (n = 40) or young animals
(n = 80) were pooled (4^65 individual organs), snap frozen in liquid
nitrogen and stored at 380‡C before analysis. Tissues were from
19 day embryo (E19) and postnatal rats on day 0, 2, 6, 12, 16, and
42 (p0^p42).
Vitamin A de¢ciency was induced in specially prepared weanling
male rats as described earlier [17]. When the rats reached a plateau in
growth rate, they were divided into two groups. The de¢cient group
(A3) was maintained on the diet without supplementation; the re-
pleted groups (RA+, ROL+) were supplemented orally with all-trans
RA (100 Wg/day) and retinol (1.5 mg/day) in 0.1 ml corn oil for 1 week
and 4 days, respectively. Rats from each group were killed, stomach
and small intestine were quickly removed, and the contents were
washed in cold phosphate-bu¡ered saline (PBS) and frozen in liquid
nitrogen and stored at 380‡C till analyzed.
2.3. Northern analysis
Total tissue RNAs were isolated with the TRI pure extraction re-
agent according to the manufacturer’s protocol. 15 Wg of total RNA
was separated in 1.1% agarose gels containing 1.2% formaldehyde and
1UMOPS running bu¡er. RNA was transferred to nytran membranes
by capillary blotting using 10USSC and cross-linked to the membrane
by UV irradiation. The blots were prehybridized and hybridized at
68‡C using Quickhyb reagent. Blots were washed twice with 2USSC,
0.1% SDS at room temperature for 15 min and then washed with
0.1USSC, 0.1% SDS at 65‡C for 30 min. Actin (2.0 kb, Oncor, Gai-
thersburg, MD) was used as a control probe. All cDNA probes were
labeled with [32P]dCTP using Prime-It random prime kit.
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2.4. Western blot analysis
Tissues were homogenized in 1.0 ml of 100 mM ice-cold Tris bu¡er
(pH 8.0) containing 3 mM EDTA, 1 Wg/ml leupeptin and pepstatin,
0.5 mM PMSF. The homogenates were centrifuged at 10 000Ug for
10 min and the supernatants were collected. 20 Wg of total protein
(determined by the method of Bradford) [18] was boiled in sample
bu¡er, separated by 8% polyacrylamide sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis and transferred to Hybond nitrocellu-
lose (Amersham). Blots were blocked with 0.05% Tween-20 in 5%
BSA before incubation with antibodies. Immunoreactive protein was
detected using an ECL Western blotting system. The antibody raised
against phenobarbital-induced aldehyde dehydrogenase (kindly pro-
vided by Dr. Ronald Lindhal), which cross-reacts with RALDH,
was used in the Western blot analysis.
2.5. Enzyme assay
The 100 000Ug supernatant fractions from tissues were used to
assay RALDH activity. In a standard assay, 1.0 mg of supernatant
protein was incubated at pH 7.2 with 141 WM all-trans retinal in the
presence of 1.61 mM DTT, 603 WM NAD, and 0.02% Tween-80 at
37‡C for 1 h in a ¢nal volume of 250 Wl. The enzymatic product RA
formed was quanti¢ed by high pressure liquid chromatography as
described earlier [19].
3. Results and discussion
Level of RALDH transcripts in stomach and small intestine
during development is shown in Fig. 1. RALDH mRNAs are
detectable in stomach during late intrauterine development,
and reach highest levels postnatally between days 2 and 42
(p20^p42). In small intestine, the highest levels of RALDH
transcripts are observed before birth (day 19, 32 day), and
then the levels decline progressively thereafter. Changes in
mRNA levels were followed by corresponding changes in pro-
tein levels (Fig. 2) and RALDH activity (Fig. 3). Variations in
the levels of RALDH protein expression and activity paral-
leled the expression of RALDH mRNA (Figs. 1^3) in both
tissues; although a lag in protein expression compared to
mRNA expression was seen at 32 days and 42 days in stom-
ach and small intestine respectively (Figs. 1 and 2). This could
be due either to the low sensitivity of the antibody to detect
the low concentration of RALDH protein or to the high
stability of mature primary RNA transcripts.
Vitamin A de¢ciency caused an increase in the levels of
RALDH mRNA and protein in stomach and small intestine
(Figs. 4 and 5). Supplementation of either RA or retinol to
vitamin A de¢cient rats decreased RALDH mRNA and pro-
tein levels, demonstrating that vitamin A levels modulate the
expression of RALDH gene in these tissues.
Several studies have shown that RA has a well character-
ized role in the development and maintenance of epithelial
cells throughout life [1,12]. The expression of RALDH gene
in several types of epithelia including stomach and small in-
testine [11] indicates an important role of this enzyme in RA
synthesis needed for cell di¡erentiation and maturation. Dur-
ing development of the stomach, a single layer of gastric epi-
thelium becomes strati¢ed and then changes from strati¢ed to
simple columnar epithelium by day 17.5 of gestation. Just
before birth, mucus cells and parietal cells are formed. As
the rat develops, the funding mucosa shows remarkable
changes. Immediately after birth, the mucous epithelium dif-
ferentiates into short, premature fundic glands. The fundic
glands rapidly elongate from 1 day to 2 weeks after birth.
The various types of cells in fundic gland di¡erentiate and
mature in accordance with development of the animal
[20,21]. Thus, the process of di¡erentiation and maturation
of the cells of stomach epithelium occurs during postnatal
development of the rat. The observation of an increase in
the RALDH expression during postnatal development of the
stomach (Figs. 1^3) suggests a role for this enzyme in produc-
ing RA required for normal di¡erentiation and maturation.
Just before birth, intestinal mucosa of the rat displays a high
level of structural development characterized by villi lined
with a single layer of columnar epithelial cells that have well
de¢ned microvilli at their absorptive surface [22]. This struc-
tural development of the small intestine coincides with high
expression of RALDH gene, indicating crucial requirement of
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Fig. 1. Expression of RALDH mRNA in stomach (A) and small in-
testine (B) of rats during development. 15 Wg of total RNA was sep-
arated on 1.1% agarose gel as described in Section 2. Actin (2.0 kb)
was used to ensure loading of similar amounts of RNA.
Fig. 2. Western analysis of RALDH protein. Expression of RALDH protein in stomach (A) and small intestine (B) of rats during development.
20 Wg of total protein was separated on 8.% SDS-PAGE and RALDH protein was detected by immunoblot as described in Section 2.
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RA for these processes. However, it is not clear why the ex-
pression of RALDH declines after birth in the intestine,
although there is continuous removal and proliferation of in-
testinal epithelium occurs during postnatal development [23].
Studies have shown that RA is present in the small intestine of
16.5 dpc embryos and adults [24,25]. Since intestine is one of
the main organs involved in retinoid uptake, storage, turn-
over, and excretion [26], it is possible that adult small intestine
may take up RA from the circulation or absorb it from the
diet and RA present in the tissue may account for this form of
RA and not in situ generated RA. It is also possible that a
high level of RA in the adult small intestine taken up from the
circulation or absorbed from the diet may down-regulate the
expression of RALDH, as we have shown that RA levels
modulate the expression of RALDH gene (Figs. 4 and 5).
At present, the mechanism(s) by which RA down-regulates
RALDH gene in stomach and small intestine is not know.
However, it is tempting to speculate that there may be a
RA response element in the promoter of RALDH gene that
may interact with one of the nuclear RAR receptors and
regulate RALDH gene expression.
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Fig. 3. Activity of RALDH for retinal oxidation in stomach (F)
and small intestine (b) of rats during development.
Fig. 4. Comparison of RALDH transcripts in stomach (A), and
small intestine (B) from A3, RA+, and ROL+ rats. 15 Wg of total
RNA was separated on 1% agarose gels and hybridized to RALDH
cDNA followed by actin cDNA. Lanes 1, 2, 3 are RNAs from A3,
RA+ and ROL+ stomach and small intestine, respectively.
Fig. 5. Expression of RALDH protein in stomach (A) and small in-
testine (B) from A3, RA+, and ROL+ rats. Lanes 1, 2 and 3 are
proteins from A3, RA+, and ROL+ stomach and small intestine,
respectively.
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